These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23507887)

  • 1. Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.
    Ahola N; Veiranto M; Männistö N; Karp M; Rich J; Efimov A; Seppälä J; Kellomäki M
    Biomatter; 2012; 2(4):213-25. PubMed ID: 23507887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.
    Ahola N; Männistö N; Veiranto M; Karp M; Rich J; Efimov A; Seppälä J; Kellomäki M
    Biomatter; 2013; 3(2):. PubMed ID: 23507926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolytic degradation of composites of poly(L-lactide-co-epsilon-caprolactone) 70/30 and β-tricalcium phosphate.
    Ahola N; Veiranto M; Rich J; Efimov A; Hannula M; Seppälä J; Kellomäki M
    J Biomater Appl; 2013 Nov; 28(4):529-43. PubMed ID: 23048066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin containing PLLA/β-TCP controls MRSA in vitro.
    Kankilic B; Bayramli E; Kilic E; Dağdeviren S; Korkusuz F
    Clin Orthop Relat Res; 2011 Nov; 469(11):3222-8. PubMed ID: 21918801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler.
    Mäkinen TJ; Veiranto M; Lankinen P; Moritz N; Jalava J; Törmälä P; Aro HT
    J Antimicrob Chemother; 2005 Dec; 56(6):1063-8. PubMed ID: 16234335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of in vitro degradation of poly(D,L-lactide)/beta-tricalcium composite on its shape-memory properties.
    Zheng X; Zhou S; Yu X; Li X; Feng B; Qu S; Weng J
    J Biomed Mater Res B Appl Biomater; 2008 Jul; 86(1):170-80. PubMed ID: 18161831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of strain rate on the mechanical properties of tricalcium phosphate/poly(L: -lactide) composites.
    Yamadi S; Kobayashi S
    J Mater Sci Mater Med; 2009 Jan; 20(1):67-74. PubMed ID: 18704650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo investigations on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes.
    Ignatius AA; Betz O; Augat P; Claes LE
    J Biomed Mater Res; 2001; 58(6):701-9. PubMed ID: 11745524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin release from biodegradable poly-l-lactide based composites for novel intramedullary nails.
    Morawska-Chochół A; Domalik-Pyzik P; Chłopek J; Szaraniec B; Sterna J; Rzewuska M; Boguń M; Kucharski R; Mielczarek P
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():15-20. PubMed ID: 25491796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a bioactive glass fiber reinforced starch-polycaprolactone composite.
    Jukola H; Nikkola L; Gomes ME; Chiellini F; Tukiainen M; Kellomäki M; Chiellini E; Reis RL; Ashammakhi N
    J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):197-203. PubMed ID: 18386831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro elution of vancomycin from biodegradable osteoconductive calcium phosphate-polycaprolactone composite beads for treatment of osteomyelitis.
    Makarov C; Cohen V; Raz-Pasteur A; Gotman I
    Eur J Pharm Sci; 2014 Oct; 62():49-56. PubMed ID: 24859314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration.
    Patlolla A; Collins G; Arinzeh TL
    Acta Biomater; 2010 Jan; 6(1):90-101. PubMed ID: 19631769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The merit of sintered PDLLA/TCP composites in management of bone fracture internal fixation.
    Lin FH; Chen TM; Lin CP; Lee CJ
    Artif Organs; 1999 Feb; 23(2):186-94. PubMed ID: 10027889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.
    Kimishima K; Matsuno T; Makiishi J; Tamazawa G; Sogo Y; Ito A; Satoh T
    Odontology; 2016 Jan; 104(1):105-13. PubMed ID: 25533357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation and in vitro and in vivo evaluation of supercritical-CO2-foamed β-TCP/PLCL composites for bone applications.
    Pitkänen S; Paakinaho K; Pihlman H; Ahola N; Hannula M; Asikainen S; Manninen M; Morelius M; Keränen P; Hyttinen J; Kellomäki M; Laitinen-Vapaavuori O; Miettinen S
    Eur Cell Mater; 2019 Aug; 38():35-50. PubMed ID: 31381126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apatite formation in composites of alpha-TCP and degradable polyesters.
    Van Den Vreken NM; Pieters IY; De Maeyer EA; Jackers GJ; Schacht EH; Verbeeck RM
    J Biomater Sci Polym Ed; 2006; 17(9):953-67. PubMed ID: 17094635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(epsilon-caprolactone-co-DL-lactide) and bioactive glass (S53P4).
    Jaakkola T; Rich J; Tirri T; Närhi T; Jokinen M; Seppälä J; Yli-Urpo A
    Biomaterials; 2004 Feb; 25(4):575-81. PubMed ID: 14607495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment.
    Koort JK; Suokas E; Veiranto M; Mäkinen TJ; Jalava J; Törmälä P; Aro HT
    J Biomed Mater Res A; 2006 Sep; 78(3):532-40. PubMed ID: 16736479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of tetracycline from biodegradable beta-tricalcium phosphate composites.
    Luginbuehl V; Ruffieux K; Hess C; Reichardt D; von Rechenberg B; Nuss K
    J Biomed Mater Res B Appl Biomater; 2010 Feb; 92(2):341-52. PubMed ID: 19904817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored therapeutic release from polycaprolactone-silica hybrids for the treatment of osteomyelitis: antibiotic rifampicin and osteogenic silicates.
    Gritsch L; Granel H; Charbonnel N; Jallot E; Wittrant Y; Forestier C; Lao J
    Biomater Sci; 2022 Apr; 10(8):1936-1951. PubMed ID: 35258044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.